LTUS Stock Chart & Stats
<$0.01
<$0.01(31.67%)
At close: 4:00 PM EDT
<$0.01
<$0.01(31.67%)
Day’s Range― - ―
52-Week Range<$0.01 - $0.01
Previous CloseN/A
Volume325.00
Average Volume (3M)82.51K
Market Cap
$96.05K
Enterprise Value$109.75K
Total Cash (Recent Filing)$419.00
Total Debt (Recent Filing)$123.43K
Price to Earnings (P/E)―
Beta-1.96
Next EarningsN/A
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)0.00
Shares Outstanding27,816,000
10 Day Avg. Volume82,512
30 Day Avg. Volume82,512
Financial Highlights & Ratios
PEG Ratio0.00
Price to Book (P/B)-103.17
Price to Sales (P/S)0.00
P/FCF Ratio-598.56
Enterprise Value/Market Cap1.14
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/Ebitda-6.74
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
LTUS FAQ
What was Lotus Pharmaceuticals Inc’s price range in the past 12 months?
Lotus Pharmaceuticals Inc lowest stock price was <$0.01 and its highest was $0.01 in the past 12 months.
What is Lotus Pharmaceuticals Inc’s market cap?
Lotus Pharmaceuticals Inc’s market cap is $96.05K.
When is Lotus Pharmaceuticals Inc’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were Lotus Pharmaceuticals Inc’s earnings last quarter?
Currently, no data Available
Is Lotus Pharmaceuticals Inc overvalued?
According to Wall Street analysts Lotus Pharmaceuticals Inc’s price is currently Overvalued.
Does Lotus Pharmaceuticals Inc pay dividends?
Lotus Pharmaceuticals Inc does not currently pay dividends.
What is Lotus Pharmaceuticals Inc’s EPS estimate?
Lotus Pharmaceuticals Inc’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Lotus Pharmaceuticals Inc have?
Lotus Pharmaceuticals Inc has 27,816,000 shares outstanding.
What happened to Lotus Pharmaceuticals Inc’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Lotus Pharmaceuticals Inc?
Currently, no hedge funds are holding shares in LTUS
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Lotus Pharmaceuticals Inc
Lotus Pharmaceuticals, Inc. currently has no substantial business activities. Headquartered in Nashville, Tennessee, the company previously focused on the development, production, and distribution of pharmaceutical products within the People's Republic of China.
Technical Analysis
Aimei Health Technology Co., Ltd
―
Oaktree Acquisition Corp. III Life Sciences Class A
―
Drugs Made In America Acquisition Corp.
―
Enhanced Group
―
Drugs Made In America Acquisition II Corp.
―
Ownership Overview
―
Insiders
―
Mutual Funds
0.14% Other Institutional Investors
99.86% Public Companies and
Individual Investors